South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks 
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran 
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions 
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality 
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election 
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals 
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Instagram Outage Disrupts Thousands of U.S. Users 
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
MBK Partners has been tapped by Citigroup Global Markets Securities as the preferred bidder to buy Medit dental scanners and solutions firm. With this decision, the Carlyle-led consortium is now out of the bid race.
MBK Partners is a private equity company focusing on North Asia, and it is planning to buy Medit before this year ends. Things will be easier for the company because it can now start negotiating with Unison Capital which is Medit’s largest stakeholder, without having to worry about other bidders.
As per The Korea Times, sources in the industry revealed on Wednesday, Nov. 30, that Citigroup Global Markets Securities, which is serving as Medit’s sales manager, picked MBK Partners as the new preferred bidder this week.
While there are no details about the exact figures yet, it was estimated that the price of acquiring a 100% stake in the dental scanner firm would cost about KRW2.6 trillion or $2 billion in US dollars. Then again, it should be noted that the price can still change during the process of negotiation.
The estimated amount is huge, but this is actually 10% lower compared to what the Carlyle Group consortium offered in its bid in October. This consortium was formed with the GS Group, and they offered the highest bid price for Medit’s acquisition which was KRW3 trillion or $2.26 billion.
The GS-Carlyle consortium won the main bid that month, but in November, it ultimately lost its preferred bidder position due to disagreements regarding the acquisition price. Unison Capital immediately engaged in discussions with other global PEF companies, such as CVC Capital and KKR, after the fallout. Amid the talks, MBK Partners actively seized the chance for acquisition while assessing the medium and long-term growth potential of Medit on the global stage.
MBK Partners and Medit are looking to close the acquisition deal as fast as possible, so a stock purchase agreement (SPA) is expected to be signed by the end of the year. The final closing may be done before the second quarter of 2023. Pulse News reported that the acquisition involves a full stake in Medit, which is owned by its founder, Chang Min Ho, and Unison Capital.
“MBK Partners has moved fast with its decision on the investment,” an official in the industry said. “Both sides are willing to sign a stock purchase agreement before the year ends.”
